Translate AMICOR contents if you like

Monday, March 27, 2017

SGLT-2 inhibitors: Astra's Farxiga, Jardiance Lilly and Boehringer, Invokana J & J

Recomendado pelo AMICOR Reginaldo Hollanda Albuquerque (Brasília), com o comentário de que não sabe se é verdade mas vale a pena observar.
Reuters reported that research suggests SGLT-2 inhibitors, “a newer class of type 2 diabetes” medications, “significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease.” The findings were presented at the American College of Cardiology meeting.

No comments: